Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
GE Opens First New Manufacturing Operation in Louisville, Ky...
Get set for Bupa Great Birmingham Run...
New Regional Aircraft Contracts and Support...
Harris Corporation's John Shipley Honored by U.S...
Farmers can use red diesel to help out during extreme weather...
Hogan Lovells' It's Not Just Peanuts Campaign Wins Legal Business...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Caraco Pharmaceutical Laboratories Ltd declares launch of generic Eloxatin
Generic pharmaceuticals provider Caraco Pharmaceutical Laboratories Ltd (NYSE:CPD) said on Thursday that the company has introduced 50mg and 100mg oxaliplatin injections.
These oxaliplatin injections are therapeutically equivalent to Eloxatin from pharmaceutical company sanofi-aventis...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search